Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Refine USA, LLC
483
•Refine USA, LLC•August 16, 2023

FDA 483 - Refine USA, LLC - August 16, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

Refine USA, LLC, a specification developer in Jacksonville, FL, was cited for inadequate purchasing controls during an FDA inspection. The firm failed to ensure that purchased products and services conform to specified requirements. This was evidenced by a contract manufacturer making an unapproved change to the Class II "Rejuvpen NXT" device without notifying Refine USA, LLC, affecting an estimated (b)(4) units.

Company
Refine USA, LLC
Inspection Date
August 16, 2023
Product Type
Device
Office
Office of Medical Device and Radiological Health Division II
Person
  • Alex J. Wild
Open in Dashboard

ID · 028708dd-020f-4e4f-a32b-45868dd37779

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.